To our knowledge, this is the first study to examine whether a preoperative model incorporating perioperative dynamic changes in CEA and CA19-9 substantially improves predictive capability for CRLM, thereby reinforcing the rationale for continued postoperative monitoring of tumor markers. This evidence concerns the gene CEACAM5 and neoplasm.